Mankind Pharma IPO Details
The Mankind Pharma IPO is a book build issue with a total issue size of ₹4326.36 cr, and a offer for sale of 40058844 equity shares. Mankind Pharma IPO opened for subscription on Apr 25, 2023 and closed on Apr 27, 2023. Mankind Pharma IPO is set price band at ₹1026 to ₹1080 per share, with a lot size of 13 shares. Minimum investment for Retail investors was ₹14,040.00 (at the upper price band) to apply for one lot.
The basis of allotment got finalized on May 03, 2023, and listed on both the NSE and BSE on May 09, 2023.
Kfin Technologies Limited has been appointed as the registrar. IIFL Capital Services Limited, Axis Capital Limited, Jefferies India Private Limited and J.P. Morgan India Private Limited are the Book Running Lead Manager for the issue.
Before investing in the Mankind Pharma IPO, investors should review the company's financial performance, business objectives, and risk factors mentioned in the offer documents and apply before the subscription window closes.
- Price Band
- ₹ 1026 – 1080
- Lot Size
- 13
- Issue Size
- ₹4326.36 Cr
- Minimum Investment
- ₹14040 (13 Shares)
- Listing Date
- 09 May 2023
Current GMP
₹121 (+11.20%)
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
About Mankind Pharma Limited
Incorporated in 1991,Mankind Pharma Limited specializes in the manufacturing and marketing of pharmaceutical formulations for both acute and chronic therapeutic areas, along with consumer healthcare products. The company is primarily oriented towards the domestic market, which accounted for 97.6% of its total revenue for the financial year 2022. It ranks as the fourth-largest pharmaceutical company in India based on domestic sales.
With a comprehensive marketing presence across India, Mankind Pharma operates 25 manufacturing facilities nationwide and boasts one of the largest distribution networks of medical representatives in the Indian pharmaceutical industry.
Mankind Pharma IPO Promoters
Mankind Pharma Limited Promoters
- Ramesh Juneja
- Rajeev Juneja
- Sheetal Arora
- Ramesh Juneja Family Trust
- Rajeev Juneja Family Trust
- Prem Sheetal Family Trust
Promoters Holding
Holding Pre Issue
79.00%
Holding Post Issue
76.50%
Mankind Pharma IPO Objective
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects.
- Carry out the Offer for Sale of 40,058,844Equity Shares by the Selling Shareholders aggregating to ₹43,263.55 million
- Achieve the benefits of listing the Equity Shares on the Stock Exchanges. For further details
Address / Contact Info
Mankind Pharma Limited
208, Okhla Industrial Estate,
Phase-III, New Delhi 110 020
Phone : +91 11 4747 6600
Email : investors@mankindpharma.com
Website : www.mankindpharma.com
IPO Snapshot
Book Running Lead Managers
- IIFL Capital Services Limited
- Axis Capital Limited
- Jefferies India Private Limited
- J.P. Morgan India Private Limited
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Mankind Pharma IPO is a Book-building IPO with a total issue size of ₹4326.36 crore. The Mankind Pharma IPO price band is ₹1026 to 1080 per share. The Mankind Pharma IPO subscription opens on Tue, Apr 25, 2023, and closes on Thu, Apr 27, 2023. The Mankind Pharma IPO will be listed on the NSE,BSE. Kfin Technologies Limited is the registrar for the Mankind Pharma IPO.
The Mankind Pharma IPO opens on Tue, Apr 25, 2023 and closes on Thu, Apr 27, 2023
Mankind Pharma IPO Price Band is ₹1026 to 1080 per share.
Mankind Pharma IPO lot size is 13 shares, Retail investors need a minimum investment of ₹14040 based on the upper price band
The minimum investment for Mankind Pharma IPO is ₹14040, based on one lot of 13 shares at the upper price band of ₹1080 per share.
Investors can apply for the Mankind Pharma IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Thu, Apr 27, 2023. The application amount remains blocked until the Mankind Pharma IPO allotment is finalized.
Mankind Pharma IPO issue size is ₹4326.36 crores.
Mankind Pharma IPO allotment date is Wed, Jul 1, 2026.
The registrar for Mankind Pharma IPO is Kfin Technologies Limited. Investors can go to Kfin Technologies Limited website to check Mankind Pharma IPO allotment status, refund processing, and other IPO-related information.
The Mankind Pharma IPO GMP (Grey Market Premium) is ₹121 as of Tue, May 9, 2023. Based on the upper price band of ₹1080 per share, the estimated Mankind Pharma IPO listing price is ₹1201, indicating a potential listing gain of approximately 0% over the issue price.